scholarly journals AI4AMP: an Antimicrobial Peptide Predictor Using Physicochemical Property-Based Encoding Method and Deep Learning

mSystems ◽  
2021 ◽  
Author(s):  
Tzu-Tang Lin ◽  
Li-Yen Yang ◽  
I-Hsuan Lu ◽  
Wen-Chih Cheng ◽  
Zhe-Ren Hsu ◽  
...  

Antimicrobial peptides (AMPs) are innate immune components that have aroused a great deal of interest among drug developers recently, as they may become a substitute for antibiotics. New candidates need to fight antibiotic resistance, while discovering novel AMPs through wet-lab screening approaches is inefficient and expensive.

2020 ◽  
Author(s):  
Tzu-Tang Lin ◽  
Li-Yen Yang ◽  
I-Hsuan Lu ◽  
Wen-Chih Cheng ◽  
Zhe-Ren Hsu ◽  
...  

AbstractMotivationAntimicrobial peptides (AMPs) are innate immune components that have aroused a great deal of interest among drug developers recently, as they may become a substitution for antibiotics. However, AMPs discovery through traditional wet-lab research is expensive and inefficient. Thus, we developed AI4AMP, a user-friendly web-server that provides an accurate prediction of the antimicrobial activity of a given protein sequence, to accelerate the process of AMP discovery.ResultsOur results show that our prediction model is superior to the existing AMP predictors.AvailabilityAI4AMP is freely accessible at http://symbiosis.iis.sinica.edu.tw/PC_6/[email protected]


2020 ◽  
Author(s):  
Marina Sinner ◽  
Florentin Masurat ◽  
Jonathan Ewbank ◽  
Nathalie Pujol ◽  
Henrik Bringmann

AbstractWounding triggers a protective innate immune response that includes the production of antimicrobial peptides and increased sleep. Little is known, however, about how peripheral wounds signal need for sleep to the nervous system. We found that during C. elegans larval molting, a tolloid/BMP-1-like protein promotes sleep through an epidermal innate immune pathway and the expression of more than a dozen antimicrobial peptide (AMP) genes. In the adult, epidermal injury activates innate immunity and turns up AMP production to trigger sleep. We show for one AMP, NLP-29, that it acts through the neuropeptide receptor NPR-12 in neurons that depolarize the sleep-active RIS neuron to induce sleep. Sleep in turn increases the chance of surviving injury. Thus, we found a novel mechanism by which peripheral wounds signal to the nervous system to increase protective sleep. Such a long-range somnogen signaling function of AMPs might also boost sleep in other animals including humans.Highlights- Gain-of-function mutation in the tolloid/BMP-1-like NAS-38 protein increases sleep- NAS-38 activates innate immunity pathways to ramp up STAT-dependent antimicrobial peptide (AMP) expression- Wounding increases sleep through the innate immune response and AMPs- Antimicrobial peptides are long-range somnogens that act through neuronal neuropeptide receptors to depolarize a sleep-active neuron- Sleep increases the chance to survive injuryGraphical Abstract


2021 ◽  
Author(s):  
Qinze Yu ◽  
Zhihang Dong ◽  
Xingyu Fan ◽  
Licheng Zong ◽  
Yu Li

Identifying the targets of an antimicrobial peptide is a fundamental step in studying the innate immuneresponse and combating antibiotic resistance, and more broadly, precision medicine and public health. Therehave been extensive studies on the statistical and computational approaches to identify (i) whether a peptide is anantimicrobial peptide (AMP) or a non-AMP and (ii) which targets are these sequences effective to (Gram-positive,Gram-negative, etc.). Despite the existing deep learning methods on this problem, most of them are unable tohandle the small AMP classes (anti-insect, anti-parasite, etc.). And more importantly, some AMPs can havemultiple targets, which the previous methods fail to consider. In this study, we build a diverse and comprehensivemulti-label protein sequence database by collecting and cleaning amino acids from various AMP databases.To generate efficient representations and features for the small classes dataset, we take advantage of a proteinlanguage model trained on 250 million protein sequences. Based on that, we develop an end-to-end hierarchicalmulti-label deep forest framework, HMD-AMP, to annotate AMP comprehensively. After identifying an AMP, itfurther predicts what targets the AMP can effectively kill from eleven available classes. Extensive experimentssuggest that our framework outperforms state-of-the-art models in both the binary classification task and themulti-label classification task, especially on the minor classes. Compared with the previous deep learning methods,our method improves the performance on macro-AUROC by 11%. The model is robust against reduced featuresand small perturbations and produces promising results. We believe HMD-AMP contribute to both the future wet-lab investigations of the innate structural properties of different antimicrobial peptides and build promising empirical underpinnings for precise medicine with antibiotics.


1999 ◽  
Vol 67 (11) ◽  
pp. 6084-6089 ◽  
Author(s):  
Robert Bals ◽  
Daniel J. Weiner ◽  
A. David Moscioni ◽  
Rupalie L. Meegalla ◽  
James M. Wilson

ABSTRACT Antimicrobial peptides, such as defensins or cathelicidins, are effector substances of the innate immune system and are thought to have antimicrobial properties that contribute to host defense. The evidence that vertebrate antimicrobial peptides contribute to innate immunity in vivo is based on their expression pattern and in vitro activity against microorganisms. The goal of this study was to investigate whether the overexpression of an antimicrobial peptide results in augmented protection against bacterial infection. C57BL/6 mice were given an adenovirus vector containing the cDNA for LL-37/hCAP-18, a human cathelicidin antimicrobial peptide. Mice treated with intratracheal LL-37/hCAP-18 vector had a lower bacterial load and a smaller inflammatory response than did untreated mice following pulmonary challenge with Pseudomonas aeruginosa PAO1. Systemic expression of LL-37/hCAP-18 after intravenous injection of recombinant adenovirus resulted in improved survival rates following intravenous injection of lipopolysaccharide with galactosamine or Escherichia coli CP9. In conclusion, the data demonstrate that expression of an antimicrobial peptide by gene transfer results in augmentation of the innate immune response, providing support for the hypothesis that vertebrate antimicrobial peptides protect against microorganisms in vivo.


2018 ◽  
Author(s):  
Logan T. Collins ◽  
Peter B. Otoupal ◽  
Colleen M. Courtney ◽  
Anushree Chatterjee

AbstractTraditional antibiotics are reaching obsolescence as a consequence of antibiotic resistance; therefore novel antibiotic approaches are needed. A recent non-traditional approach involves formation of protein aggregates as antimicrobials to disrupt bacterial homeostasis. Previous work on protein aggregates has focused on genome mining for aggregation-prone sequences in bacterial genomes rather than on rational design of aggregating antimicrobial peptides. Here, we use a synthetic biology approach to design an artificial gene encoding the first de novo aggregating antimicrobial peptide. This artificial gene,opaL(overexpressed protein aggregator Lipophilic), disrupts bacterial homeostasis by expressing extremely hydrophobic peptides. When this hydrophobic sequence is disrupted by acidic residues, consequent aggregation and antimicrobial effect decreases. Further, to deliver this artificial gene, we developed a probiotic approach using RK2, a broad host range conjugative plasmid, to transferopaLfrom donor to recipient bacteria. We utilize RK2 to mobilize a shuttle plasmid carrying theopaLgene by adding the RK2 origin of transfer. We show thatopaLis non-toxic to the donor, allowing for maintenance and transfer since its expression is under control of a promoter with a recipient-specific T7 RNA polymerase. Upon mating of donor and recipientEscherichia coli, we observe selective growth repression in T7 polymerase expressing recipients. This technique could be used to target desired pathogens by selecting pathogen-specific promoters to controlopaLexpression. This system provides a basis for the design and delivery of novel antimicrobial peptides.ImportanceThe growing threat of antibiotic resistance necessitates new treatment options for bacterial infections that are recalcitrant to traditional antimicrobials. Existing methods usually involve small-molecule compounds which interfere with essential processes in bacterial cells. By contrast, protein aggregates operate by causing widespread disruption of bacterial homeostasis and may provide a new method for combating infections. We used rational design to create and test an aggregating de novo antimicrobial peptide, OpaL. In addition, we employed bacterial conjugation to deliver theopaLgene from donor bacteria to recipient bacteria while using a strain-specific promoter to ensure that OpaL was only expressed in targeted recipients. To the best of our knowledge, this represents the first design for a de novo peptide with aggregation-mediated antimicrobial activity. We envision that OpaL’s design parameters could be used in developing a new class of antimicrobial peptides to help treat antibiotic resistant infections.


2020 ◽  
Author(s):  
Chenkai Li ◽  
Darcy Sutherland ◽  
S. Austin Hammond ◽  
Chen Yang ◽  
Figali Taho ◽  
...  

Abstract Antibiotic resistance is a growing global health concern prompting researchers to seek alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) are emerging therapeutic agents with promising utility in this domain and using in silico methods to discover novel AMPs is a strategy that is gaining interest. Such methods can filter through large volumes of candidate sequences and reduce lab screening costs. Here we introduce AMPlify, an attentive deep learning model for AMP prediction, and demonstrate its utility in prioritizing peptide sequences derived from the Rana [Lithobates] catesbeiana (bullfrog) genome. We tested the bioactivity of our predicted peptides against a panel of bacterial species, including representatives from the World Health Organization’s “priority pathogens” list. Four of our novel AMPs were active against multiple species of bacteria, including a multi-drug resistant isolate of carbapenemase-producing Escherichia coli, demonstrating the utility of tools like AMPlify in our fight against antibiotic resistance.


2021 ◽  
Author(s):  
Yuguo Zha ◽  
Cheng Chen ◽  
Qihong Jiao ◽  
Xiaomei Zeng ◽  
Xuefeng Cui ◽  
...  

Antibiotic resistance genes (ARGs) have emerged in pathogens and spread faster than expected, arousing a worldwide concern. Current methods are suitable mainly for the discovery of close homologous ARGs and have limited utility for discovery of novel ARGs, thus rendering the profiling of ARGs incomprehensive. Here, an ontology-aware deep learning model, ONN4ARG (http://onn4arg.xfcui.com/), is proposed for the discovery of novel ARGs based on multi-level annotations. Experiments based on billions of candidate microbial genes collected from various environments show the superiority of ONN4ARG in comprehensive ARG profiling. Enrichment analyses show that ARGs are both environment-specific and host-specific. For example, resistance genes for rifamycin, which is an important antibacterial agent active against gram-positive bacteria, are enriched in Actinobacteria and in soil environment. Case studies verified ONN4ARG's ability for novel ARG discovery. For example, a novel streptomycin resistance gene was discovered from oral microbiome samples and validated through wet-lab experiments. ONN4ARG provides a complete picture of the prevalence of ARGs in microbial communities as well as guidance for detection and reduction of the spread of resistance genes.


Author(s):  
Chenkai Li ◽  
Darcy Sutherland ◽  
S. Austin Hammond ◽  
Chen Yang ◽  
Figali Taho ◽  
...  

AbstractAntibiotic resistance is a growing global health concern prompting researchers to seek alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) are emerging therapeutic agents with promising utility in this domain and using in silico methods to discover novel AMPs is a strategy that is gaining interest. Such methods can filter through large volumes of candidate sequences and reduce lab screening costs. Here we introduce AMPlify, an attentive deep learning model for AMP prediction, and demonstrate its utility in prioritizing peptide sequences derived from the Rana [Lithobates] catesbeiana (bullfrog) genome. We tested the bioactivity of our predicted peptides against a panel of bacterial species, including representatives from the World Health Organization’s “priority pathogens” list. Four of our novel AMPs were active against multiple species of bacteria, including a multi-drug resistant isolate of carbapenemase-producing Escherichia coli, demonstrating the utility of tools like AMPlify in our fight against antibiotic resistance.


2020 ◽  
Vol 21 (2) ◽  
pp. 90-96 ◽  
Author(s):  
Girish M. Bhopale

Antimicrobial drugs resistant microbes have been observed worldwide and therefore alternative development of antimicrobial peptides has gained interest in human healthcare. Enormous progress has been made in the development of antimicrobial peptide during the last decade due to major advantages of AMPs such as broad-spectrum activity and low levels of induced resistance over the current antimicrobial agents. This review briefly provides various categories of AMP, their physicochemical properties and mechanism of action which governs their penetration into microbial cell. Further, the recent information on current status of antimicrobial peptide development, their applications and perspective in human healthcare are also described.


Sign in / Sign up

Export Citation Format

Share Document